The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model

The NK1 receptor antagonist N-acetyl-l-tryptophan reduces dyskinesia in a hemi-parkinsonian rodent model

Background: Dyskinesia or abnormal involuntary movements (AIMs) are a disabling effect of chronic l-DOPA administration and consequent pulsatile stimulation of dopamine receptors. This abnormal activation causes maladaptive changes including upregulation of FosB expression in dynorphin containing st...

Bibliográfalaš dieđut
Váldodahkkit:	Thornton, E, Hassall, M, Corrigan, F, Vink, R
Materiálatiipa:	Journal article
Giella:	English
Almmustuhtton:	Elsevier 2014

Geahča maid

Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats
Dahkki: Cantuti-Castelvetri, Ippolita, et al.
Almmustuhtton: (2011)

In vivo evidence of D3 dopamine receptor sensitization in parkinsonian primates and rodents with l-DOPA-induced dyskinesias
Dahkki: Rosario Sánchez-Pernaute, et al.
Almmustuhtton: (2007-08-01)

Transplantation of melanocytes obtained from the skin ameliorates apomorphine-induced abnormal behavior in rodent hemi-parkinsonian models.
Dahkki: Masato Asanuma, et al.
Almmustuhtton: (2013-01-01)

Parkinsonian patients and poor awareness of dyskinesias.
Dahkki: Sara ePietracupa, et al.
Almmustuhtton: (2014-03-01)

Effect of a selective glutamate antagonist on l-dopa-induced dyskinesias in drug-naive parkinsonian monkeys
Dahkki: Abdallah Hadj Tahar, et al.
Almmustuhtton: (2004-03-01)

Systematic Evaluation of DBS Parameters in the Hemi-Parkinsonian Rat Model
Dahkki: Soheil Mottaghi, et al.
Almmustuhtton: (2020-10-01)

The beneficial effect of the flavonoid quercetin on behavioral changes in hemi-Parkinsonian rats
Dahkki: Mehdi Mehdizadeh, et al.
Almmustuhtton: (2010-01-01)

The beneficial effect of the flavonoid quercetin on behavioral changes in hemi-Parkinsonian rats
Dahkki: Mehdi Mehdizadeh, et al.
Almmustuhtton: (2010-01-01)

7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate
Dahkki: M. T. Herrero, et al.
Almmustuhtton: (2023-05-01)

Propranolol Relieves L-Dopa-Induced Dyskinesia in Parkinsonian Mice
Dahkki: Ziqing Shi, et al.
Almmustuhtton: (2020-11-01)

Synergistic Effects of Adenosine A2A Antagonist and L-DOPA on Rotational Behaviors in 6-Hydroxydopamine-Induced Hemi-Parkinsonian Mouse Model
Dahkki: Takahiro Matsuya, et al.
Almmustuhtton: (2007-01-01)

Prevention of L-Dopa-Induced Dyskinesias by MPEP Blockade of Metabotropic Glutamate Receptor 5 Is Associated with Reduced Inflammation in the Brain of Parkinsonian Monkeys
Dahkki: Marc Morissette, et al.
Almmustuhtton: (2022-02-01)

A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys
Dahkki: Daniella Rylander, et al.
Almmustuhtton: (2010-09-01)

IRC-082451, a novel multitargeting molecule, reduces L-DOPA-induced dyskinesias in MPTP Parkinsonian primates.
Dahkki: Romina Aron Badin, et al.
Almmustuhtton: (2013-01-01)

Substance P and its tachykinin NK1 receptor: a novel neuroprotective target for Parkinson′s disease
Dahkki: Emma Thornton, et al.
Almmustuhtton: (2015-01-01)

CCK-8S inhibits L-dopa-induced dyskinesias in parkinsonian squirrel monkeys.
Dahkki: Boyce, S, et al.
Almmustuhtton: (1990)

Potential efficacy of nanocurcumin on levodopa-induced dyskinesia in a rat parkinsonian model
Dahkki: Pegah Ashrafi, et al.
Almmustuhtton: (2022-11-01)

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates
Almmustuhtton: (2013-01-01)

Correction: IRC-082451, a Novel Multitargeting Molecule, Reduces L-DOPA-Induced Dyskinesias in MPTP Parkinsonian Primates.
Dahkki: Romina Aron Badin, et al.
Almmustuhtton: (2013-01-01)

The adenosine A2A receptor antagonist/inverse agonist, KW-6356 enhances the anti-parkinsonian activity of L-DOPA with a low risk of dyskinesia in MPTP-treated common marmosets
Dahkki: Yutaro Ohno, et al.
Almmustuhtton: (2023-07-01)

Advancing age and the rs6265 BDNF SNP are permissive to graft-induced dyskinesias in parkinsonian rats
Dahkki: Natosha M. Mercado, et al.
Almmustuhtton: (2024-08-01)

Intensive Rehabilitation Treatment in Parkinsonian Patients with Dyskinesias: A Preliminary Study with 6-Month Followup
Dahkki: Giuseppe Frazzitta, et al.
Almmustuhtton: (2012-01-01)

Spontaneous locomotor activity and L-DOPA-induced dyskinesia are not linked in 6-OHDA parkinsonian rats
Dahkki: Stefania eSgroi, et al.
Almmustuhtton: (2014-10-01)

Chronic Nasal Administration of Kisspeptin-54 Regulates Mood-Related Disorders Via Amygdaloid GABA in Hemi-Parkinsonian Rats
Dahkki: Osman Sinen, et al.
Almmustuhtton: (2024-11-01)

Molecular Insights into the Interaction of Tryptophan Metabolites with the Human Aryl Hydrocarbon Receptor in Silico: Tryptophan as Antagonist and no Direct Involvement of Kynurenine
Dahkki: Abdulla A-B Badawy, et al.
Almmustuhtton: (2024-09-01)

NK1-r Antagonist Treatment Comparable to Decompressive Craniectomy in Reducing Intracranial Pressure Following Stroke
Dahkki: Annabel J. Sorby-Adams, et al.
Almmustuhtton: (2019-07-01)

The locus coeruleus is directly implicated in L-DOPA-induced dyskinesia in parkinsonian rats: an electrophysiological and behavioural study.
Dahkki: Cristina Miguelez, et al.
Almmustuhtton: (2011-01-01)

AV-101, a Pro-Drug Antagonist at the NMDA Receptor Glycine Site, Reduces L-Dopa Induced Dyskinesias in MPTP Monkeys
Dahkki: Mélanie Bourque, et al.
Almmustuhtton: (2022-11-01)

Dynamic Involvement of Striatal NG2-glia in L-DOPA Induced Dyskinesia in Parkinsonian Rats: Effects of Doxycycline
Dahkki: G.C. Nascimento, et al.
Almmustuhtton: (2023-03-01)

Dopaminergic-like neurons derived from oral mucosa stem cells by developmental cues improve symptoms in the hemi-parkinsonian rat model.
Dahkki: Javier Ganz, et al.
Almmustuhtton: (2014-01-01)

The Advances in Antipsychotics-Induced Dyskinesia Rodent Models: Benefits of Antioxidant Supplementation
Dahkki: Uros Velickovic, et al.
Almmustuhtton: (2025-02-01)

ANTIEMETIC ACTIVITY OF NEUROKININ NK1 RECEPTOR ANTAGONISTS IS MEDIATED CENTRALLY IN THE FERRET
Dahkki: Gardner, C, et al.
Almmustuhtton: (1994)

5-Hydroxy-tryptophan for the treatment of l-DOPA-induced dyskinesia in the rat Parkinson's disease model
Dahkki: Elisabetta Tronci, et al.
Almmustuhtton: (2013-12-01)

Short and Long Term Behavioral and Pathological Changes in a Novel Rodent Model of Repetitive Mild Traumatic Brain Injury.
Dahkki: Kelly M McAteer, et al.
Almmustuhtton: (2016-01-01)

Denervation and repeated l-DOPA induce a coordinate expression of the transcription factor NGFI-B in striatal projection pathways in hemi-parkinsonian rats
Dahkki: Michel St-Hilaire, et al.
Almmustuhtton: (2003-10-01)

Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia
Dahkki: Koki Nagaoka, et al.
Almmustuhtton: (2021-05-01)

POS-431 ALTERED REGULATION OF TRYPTOPHAN METABOLISM AND ARYL HYDROCARBON RECEPTOR DISTRIBUTION IN RODENT POLYCYSTIC KIDNEYS
Dahkki: S. Nagao, et al.
Almmustuhtton: (2021-04-01)

A sequential methodology for integral evaluation of motor and non-motor behaviors in parkinsonian rodents
Dahkki: Luis O. Soto-Rojas, et al.
Almmustuhtton: (2020-01-01)

Systemic administration of an mGluR5 antagonist, but not unilateral subthalamic lesion, counteracts l-DOPA-induced dyskinesias in a rodent model of Parkinson's disease
Dahkki: Giovanna Levandis, et al.
Almmustuhtton: (2008-01-01)

Validation of a Precise Impactor in a Rodent Cervical Spinal Cord Injury Hemi-Contusion Model
Dahkki: Jose A. Castillo, et al.
Almmustuhtton: (2024-11-01)